Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3602-3610
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3602
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3602
L-TME(n = 58) | R-TME(n = 53) | P value | |
Age1 (yr) | 66 (33-80) | 66 (42-84) | 0.597 |
Sex | 0.031 | ||
Male | 42 (72.4) | 27 (50.9) | |
Female | 16 (27.6) | 26 (49.1) | |
BMI1 (kg/m2) | 24.6 (19-37) | 24.6 (18-31) | 0.512 |
ASA score | 0.082 | ||
1 | 7 (12.1) | 11 (20.8) | |
2 | 31 (53.4) | 33 (62.3) | |
3 | 20 (34.5) | 9 (16.9) | |
Neoadjuvant therapy | 25 (43.1) | 26 (49.1) | 0.571 |
Tumour location from anal verge1 (cm) | 8 (3-12) | 8 (4-12) | 0.607 |
CEA1 | 1.55 (0.6-51.6) | 1.65 (0.5-11.1) | 0.803 |
CA 19.91 | 7.85 (0.8-241) | 7.5 (2-905) | 0.896 |
- Citation: Feroci F, Vannucchi A, Bianchi PP, Cantafio S, Garzi A, Formisano G, Scatizzi M. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery. World J Gastroenterol 2016; 22(13): 3602-3610
- URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3602